Market reporting

As 2022 draws to a close, life sciences market analysts attempt to correctly predict what the next 12 months might bring to the drug discovery sector. DDW’s Diana Spencer summarises the key trends likely to impact the market in 2023.  1. There will be greater emphasis on diversity in clinical trials A focus on the representation of […]

Myeloma Patients Europe (MPE) has launched an advocacy report on addressing access barriers to myeloma clinical trials in Central and Eastern Europe (CEE).   The report, led by the MPE CEE Workgroup on Access, found huge inequalities for patients, confirming reports from MPE CEE members about a lack of clinical trials opening in the region and […]

With European life sciences R&D investment at a 20-year low, biopharmaceutical associations and MEPs are calling on the EU to modernise its policies. DDW’s Diana Spencer asks what will be needed for Europe to compete in the growing global market for advanced therapies.  A new report by Charles River Associates for the European Federation of […]

After a disappointing start to the year, the last few months have seen a boost to fundraising for UK biotech companies. DDW’s Diana Spencer unpacks the Q3 figures and annual predictions from the BioIndustry Association1.  While 2021 was the highest year on record for investments into UK biotech and life sciences companies, it looks unlikely […]

DDW Multimedia Editor Megan Thomas takes a broad look at the drug discovery and development landscape in Japan and highlights how it is bolstered by government policies, investment, collaboration, start-up ecosystems and academic research.   Japan continues to be one of the largest pharmaceutical markets in the world, despite what the International Trade Administration described as […]

Dr Stephan Emmerth and Paul Eschmann, Basel Area Business & Innovation, explain the benefits of being based in Basel – the talent pool, global players, academic institutions and investors, for example.  Companies specialising in oncology R&D and therapeutics continue to spring up all around the globe, often spun out of universities working on the latest […]

As we start to look beyond the pandemic, which areas of Europe’s drug discovery community should we take note of? Lu Rahman highlights some of the key players.  The European drug discovery sector is buoyant. Valued at $14.8 billion in 2020, the sector is expected to grow by 8.3% until 2030. This growth is due […]

Listen to this article on the DDW Podcast: Lu Rahman takes a snapshot of the US biotech market and how its successes are having a positive effect on its UK counterpart. These are uncertain times for global markets. As the world attempts to recover from the Covid-19 pandemic, the fall-out from the conflict in Ukraine has […]

This most recent report by the Comptroller and Auditor General examines the rollout of the Covid-19 vaccination programme in England up to the end of October 2021, focusing on events up to the end of October 2021 and assessing whether the programme is well placed to meet its objectives in full. The National Audit Office […]

DDW’s Megan Thomas looks at three regions and their approach to digitalisation. 1. United Kingdom  A report published by the Association of the British Pharmaceutical Industry (ABPI) has identified the skills and training conditions needed for the future success of UK life sciences. George Freeman, Minister for Science, Research, and Innovation at the Department for […]

The top 20 global innovative bio/pharma companies* reported a 24.9% growth in aggregate market capitalisation (MCAP)—from $2.8 trillion on 31 December 2020 to $3.4 trillion as of 31 December 2021, according to GlobalData.   The data and analytics company notes that a positive year-on-year MCAP growth was reported for 14 of the top players, with five […]

Not only is there is a severe lack of effective T-cell lymphoma (TCL) treatments, according to GlobalData, but the data and analytics company does not expect any significant solutions to appear in the next decade.  Context  According to GlobalData, one key unmet need is found in the cutaneous TCL (CTCL) subtype. Early-stage CTCL has a favourable prognosis and is […]

Listen to this article on the DDW Podcast: As part of the Fall Issue of DDW’s Market Report, Dr Henry Li, CSO, Crown Bioscience examines cycles of innovation in the Chinese life sciences industry and how they provide opportunities for global drug discovery breakthroughs.  Drug research and development in China has changed dramatically since the turn of […]

CRB has released an industry report based on survey responses from more than 500 industry leaders and with unique analysis from CRB’s life sciences subject matter experts.  What is in the report?  Warp speed delivery: Speed to market is a more significant business driver in a post “warp speed” delivery environment – even as companies face […]

The global drug discovery informatics market size is expected to reach $5.62 billion by 2028 according to a new study by Polaris Market Research. The report gives insight into current market dynamics and provides analysis on future market growth.  The report is called “Drug Discovery Informatics Market Share, Size, Trends, Industry Analysis Report, By Workflow […]

Examining the role of the pharmaceutical industry in alleviating challenges is helpful to understand how people are benefiting from innovative medicines. This report examines the impact of the pharmaceutical industry in nine Latin American countries (Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Mexico, Panama, and Peru) by analysing its impact across two dimensions of value: economic impact and societal-human […]